Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Interleukin 6 Is Not Made By Chimeric Antigen Receptor T Cells and Does Not Impact Their Function

David M. Barrett, MD PhD, Nathan Singh, MD, Ted J. Hofmann, PhD, Zachary Gershenson, Stephan A. Grupp, MD PhD

Blood (2016) 128 (22): 654.

https://doi.org/10.1182/blood.V128.22.654.654

Published: 2016

Journal Articles

Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies

Marco Ruella, MD, David M. Barrett, MD PhD, Saad S Kenderian, MD, Olga Shestova, PhD, Ted J. Hofmann, PhD, John Scholler, Simon F. Lacey, PhD BSc, J. Joseph Melenhorst, PhD, Farzana Nazimuddin, Jessica Perazzelli, PhD, David A Christian, PhD, Christopher A Hunter, PhD, David L Porter, MD, Carl H. June, MD, Stephan A. Grupp, MD PhD, Saar I Gill, MBBS, PhD

Blood (2015) 126 (23): 2523.

https://doi.org/10.1182/blood.V126.23.2523.2523

Published: 2015

Journal Articles

Novel Chimeric Antigen Receptor T Cells for the Treatment of CD19-Negative Relapses Occurring after CD19-Targeted Immunotherapies

Marco Ruella, MD, David Barrett, MD PhD, Saad S. Kenderian, MD, Olga Shestova, PhD, Ted J. Hofmann, PhD, John Scholler, Simon F. Lacey, PhD BSc, Jan J Melenhorst, PhD, Farzana Nazimuddin, MS, Michael Kalos, PhD, David L. Porter, MD, Carl H. June, MD, Stephan A. Grupp, MD PhD, Saar I. Gill, MD PhD

Blood (2014) 124 (21): 966.

https://doi.org/10.1182/blood.V124.21.966.966

Published: 2014

Journal Articles

Expansion of the Endosteal Hematopoietic Stem Cell Niche Following Myeloablative and Reduced Intensity Conditioning Is Triggered By Hematopoietic Cell Loss

Timothy S. Olson, MDPhD, Satoru Otsuru, MDPhD, Ted J. Hofmann, PhD, Massimo Dominici, MD, Edwin M. Horwitz, MDPhD

Blood (2014) 124 (21): 1090.

https://doi.org/10.1182/blood.V124.21.1090.1090

Published: 2014

Journal Articles

0.1 Grams of Sub-Cutaneous Adipose Tissue (SCAT) as Source of Adult Multipotent Mesenchymal Stromal Cells (MSC) for Cell-Based Therapies.

Massimo Dominici, MD, Rita Sternieri, MD, Domenico De Fazio, MD, Luigi Cafarelli, MS, Giovanni Guaraldi, MD, Carlotta Spano, MS, Valeria Rasini, PhD, Paolo Paolucci, MD, PhD, Michele Cilli, VMD, Federica Piccardi, MS, Giuseppe Astori, PhD, Ted J. Hofmann, PhD, Edwin M. Horwitz, MD, PhD, Pierfranco Conte, MD, PhD

Blood (2007) 110 (11): 4915.

https://doi.org/10.1182/blood.V110.11.4915.4915

Published: 2007

Journal Articles

GD2+ Selected Mesenchymal Stromal Cells (MSCs) Demonstrate a More Robust Proliferation and Differentiation Potential Compared to Unselected Cells.

Caridad Martinez, MD, Ted J. Hofmann, PhD, Roberta Marino, MS, Massimo Dominici, MD, Edwin M. Horwitz, MD, PhD

Blood (2007) 110 (11): 1919.

https://doi.org/10.1182/blood.V110.11.1919.1919

Published: 2007

Journal Articles

Early Kinetics of Bone Marrow Cell Engraftment in Bone after Transplantation: Insights into the Mechanism of Engraftment.

John E. Garlits, MS, Massimo Dominici, MD, Ted J. Hofmann, PhD, Edwin M. Horwitz, MD, PhD

Blood (2004) 104 (11): 1294.

https://doi.org/10.1182/blood.V104.11.1294.1294

Published: 2004

NARROW

Interleukin 6 Is Not Made By Chimeric Antigen Receptor T Cells and Does Not Impact Their Function

Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies

Novel Chimeric Antigen Receptor T Cells for the Treatment of CD19-Negative Relapses Occurring after CD19-Targeted Immunotherapies

Expansion of the Endosteal Hematopoietic Stem Cell Niche Following Myeloablative and Reduced Intensity Conditioning Is Triggered By Hematopoietic Cell Loss

0.1 Grams of Sub-Cutaneous Adipose Tissue (SCAT) as Source of Adult Multipotent Mesenchymal Stromal Cells (MSC) for Cell-Based Therapies.

GD2+ Selected Mesenchymal Stromal Cells (MSCs) Demonstrate a More Robust Proliferation and Differentiation Potential Compared to Unselected Cells.

Early Kinetics of Bone Marrow Cell Engraftment in Bone after Transplantation: Insights into the Mechanism of Engraftment.

Email alerts

ASH Publications

American Society of Hematology

Interleukin 6 Is Not Made By Chimeric Antigen Receptor T Cells and Does Not Impact Their Function

Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies

Novel Chimeric Antigen Receptor T Cells for the Treatment of CD19-Negative Relapses Occurring after CD19-Targeted Immunotherapies

Expansion of the Endosteal Hematopoietic Stem Cell Niche Following Myeloablative and Reduced Intensity Conditioning Is Triggered By Hematopoietic Cell Loss

0.1 Grams of Sub-Cutaneous Adipose Tissue (SCAT) as Source of Adult Multipotent Mesenchymal Stromal Cells (MSC) for Cell-Based Therapies.

GD2+ Selected Mesenchymal Stromal Cells (MSCs) Demonstrate a More Robust Proliferation and Differentiation Potential Compared to Unselected Cells.

Early Kinetics of Bone Marrow Cell Engraftment in Bone after Transplantation: Insights into the Mechanism of Engraftment.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only